Scienza e Tecnologia
Global Fetal Bovine Serum Market Expected to Generate a Revenue of $1,568,586.4 thousand by 2028, Growing at a CAGR of 6.4% from 2021-2028 - Exclusive Report [199 Pages] By Research Dive
The is expected to garner a revenue of by 2028, exponentially growing at a during the forecast period (2021-2028).
Fetal bovine serum is extensively used as a growth supplement for the cell culture due to the availability of low-level antibodies and complex composition of protein components, which is pertinent for cells growth. In addition, rising research and development activities in life science is further expected to drive the growth of the market during the forecast period. However, increasing prevalence of supplement for fetal bovine serum is anticipated to restrain the growth of the market in the projected timeframe. However, persistent technological advancements and increased emphasis on animal-based drugs and medicines are expected to create massive opportunities for the growth of the market during the forecast period.
The outbreak of coronavirus has had moderate impact on the global fetal bovine serum market. The demand for fetal bovine serum was consequently reduced to the emergence of lockdowns which resulted in complete closure of various academic and research institutions. But the pandemic also had a progressive impact on the market, owing to the immediate need for an effective anti-viral drug for the treatment of surging coronavirus infections across the globe.
The report has divided the market into various segments based on application, end-user, and region.
1. GE Healthcare
2. PAN-Biotech
3. Rocky Mountain Biologicals
4. Biowest
5. Biological Industries
6. Thermo Fischer Scientific Inc.
7. HiMedia Laboratories Pvt., Ltd.
8. Tissue Culture Biologica
9. Cell Culture Technologies LLC
10. Nucleus Biologics Psychemedics
-
These players are working on developing strategies such as product development, merger and acquisition, partnerships and collaborations to sustain the market growth.
For instance, in January 2018 , Bio-Techne, a leading developer and manufacturer of high-quality purified proteins and reagent solutions, acquired Atlanta Biologicals Inc., a professionally managed global pharmaceutical company, in order to extend Bio-Techne's cell culture and tissue regeneration capabilities.
The report also summarizes many important aspects including financial performance of the key players, SWOT analysis, product portfolio, and latest strategic developments.re and tissue regeneration capabilities.
Research Dive is a market research firm based in Pune, India . Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 ( India )
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521
Logo : https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg